Phase I Clinical Trial Using an Anticd25-Dga

Vitetta, Ellen S.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project--Cooperative Agreements (U01)
• Project #: 5U01CA058247-03
• Application #: 2098950
• Study Section: Special Emphasis Panel (SRC (74))
• Project Start: 1992-09-30
• Project End: 1998-03-01
• Budget Start: 1994-09-30
• Budget End: 1998-03-01
• Support Year: 3
• Fiscal Year: 1994

Institution

• Name: University of Texas Sw Medical Center Dallas
• Department: Microbiology/Immun/Virology
• Type: Schools of Medicine
• City: Dallas
• State: TX
• Country: United States
• Zip Code: 75390

Publications

Thrush, G R; Lark, L R; Clinchy, B C et al. (1996) Immunotoxins: an update. Annu Rev Immunol 14:49-71

Borvak, J; Chou, C S; Van Dyke, G et al. (1996) The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus. J Infect Dis 174:850-3